compostos, composições farmacêuticas contendo os mesmos, e processos de uso para os mesmos

A pharmaceutical composition comprising a pharmaceutical diluent and a compound of formula IV wherein R 21 = H, C 1 -C 20 alkyl, cycloalkyl, alkenyl, aryl, arylalkyl, or alkylaryl, -CH 2 OR 25 , -C(O)R 25 , -CO(O)R 25 , -C(O)NR 25 R 26 , -CH 2 C(O)R 25 , or -CH 2 C(O)NHR 25 , where R 25 and R 26 are...

Full description

Saved in:
Bibliographic Details
Main Authors Jill M. Mcfadden, Craig A.Townsend, Jagan Thupari, Francis P. Kuhadja, Susan M. Medghalchi
Format Patent
LanguagePortuguese
Published 16.05.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A pharmaceutical composition comprising a pharmaceutical diluent and a compound of formula IV wherein R 21 = H, C 1 -C 20 alkyl, cycloalkyl, alkenyl, aryl, arylalkyl, or alkylaryl, -CH 2 OR 25 , -C(O)R 25 , -CO(O)R 25 , -C(O)NR 25 R 26 , -CH 2 C(O)R 25 , or -CH 2 C(O)NHR 25 , where R 25 and R 26 are each independently H, C 1 -C 10 alkyl, cycloalkyl, alkenyl, aryl, arylalkyl, or alkylaryl, optionally containing one or more halogen atoms. R 22 = -OH, -OR 27 , -OCH 2 C(O)R 27 , -OCH 2 C(O)NHR 27 , -OC(O)R 27 , -OC(O)OR 27 , -OC(O)NHNH-R 5 , or -OC(O)NR 27 R 28 , where R 2 and R 28 are each independently H, C 1 -C 20 alkyl, cycloalkyl, alkenyl, aryl, arylalkyl, or alkylaryl, and where R 27 and R 28 can each optionally contain halogen atoms; R 23 and R 24 , the same or different from each other, are C 1 -C 20 alkyl, cycloalkyl, alkenyl, aryl, arylalkyl, or alkylaryl. Methods of using such formulations for the treatment of cancer, to effect weight loss, to treat microbially-based infections, to inhibit neuropeptide-Y and/or fatty acid synthase, and to stimulate CPT-1.
Bibliography:Application Number: BR20030312649